Australian Genome Research Facility

Site

AGRF – Melbourne MT

Accreditation No.

14332

Site No.

24278

Date of Accreditation

02 Jul 2018

Address

Level 13 , Victorian Comprehensive Cancer Centre , 305 Grattan Street
Melbourne, VIC 3000
Australia

agrf.org.au

Contact

Miss Melanie O'Keefe P: +61 (03) 93213727

Availability

Services available to external clients

Supervision

Not Applicable

Australian Genome Research Facility address map

Scope of Accreditation

Print scopes
AGRF – Melbourne MT

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Molecular genetics - DNA extraction Blood; Buccal swabs; Formalin-fixed paraffin-embedded (FFPE) tissues; Saliva DNA storage for future analyses; Purified PCR product; Viable DNA; Viable DNA for sequencing and other molecular assays
Blood; Buccal swabs; Saliva DNA storage for future analyses; Purified PCR product; Viable DNA; Viable DNA for sequencing
Buffy coat DNA storage for future analyses; Purified PCR product; Viable DNA; Viable DNA for sequencing
Plasma; Serum DNA storage for future analyses; Purified PCR product; Viable DNA; Viable DNA for sequencing
Molecular genetics - DNA fragment size analysis Fluorescent-labelled DNA sequencing reaction product DNA fragment size determination
Molecular genetics - DNA sequencing Extracted DNA Sequenced DNA by Sanger sequencing; Sequenced DNA utilising massively parallel sequencing technologies
Molecular genetics - Heterozygous loci determinations Extracted DNA Nucleic acid analysis for specific variants
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes Blood; Extracted DNA; Mouth swabs Cystic fibrosis transmembrane conductance regulator (CFTR)
Fragile X syndrome (FRAXA); Nucleic acid analysis for specific variants; Spinal muscular atrophy
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Whole exome sequencing studies for inherited (germline) DNA/RNA changes Extracted DNA Nucleic acid analysis for unknown variants
Molecular genetics - Predictive genetic testing - Targeted genes Buccal swabs; Extracted DNA; Saliva Polygenic risk score (PRS) - Glaucoma
Molecular genetics - RNA extraction Formalin-fixed paraffin-embedded (FFPE) tissues Purified PCR product; RNA storage for future analyses; Viable RNA; Viable RNA for molecular diagnostics; Viable RNA for sequencing
Molecular genetics - Screening for an unknown mutation - Microarray analysis for inherited (germline) DNA/RNA changes Extracted DNA Nucleic acid analysis for unknown variants
Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes Formalin-fixed paraffin-embedded (FFPE) tissues RNA; Solid tumours
Molecular genetics - Screening for an unknown mutation - Whole genome sequencing studies for inherited (germline) DNA/RNA changes Extracted DNA Nucleic acid analysis for unknown variants
Molecular genetics/Cytogenetics - Bioinformatic analysis DNA sequences; FASTQ files Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.